• Prostate cancer: Better prognosis with a triple therapy

    In a recent study, a significant improvement in PFS probability was observed in the treatment of patients with advanced castration-resistant prostate cancer through the use of ribociclib, docetaxel and prednisone.

  • Severe COVID-19 course with cancer: Impaired immune response may be the cause

    Patients with cancer who are infected with the coronavirus have an increased risk of severe COVID-19 disease.

  • These are the highlights at ASCO 2021

    This year's programme again includes advances in screening, treatment and also prevention of a wide range of tumor entities.

  • 1 |
  • 2 |